They comment that if the results obtained in the diet-induced obesity mouse model are transposable to humans, targeting the regulator of the leptin receptor rather than the receptor itself (either by RNA interference or by pharmacological antagonists), could be a more appropriate basis for identifying potential new therapeutic targets for a variety of diseases, including obesity. Here, LEPR is linked to obesity due to melanocortin 4 receptor deficiency.